Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 8/20 | 0.39 |
| ▸ | CES1 | P23141 | 5/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | SELP | P16109 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5712972 | 1.00 | CA12 (0.41) | CA12CA2CA7CA9CA14 | |
| SCHEMBL4616976 | 0.93 | CNR2 (0.50) | FAAHCES1MEN1KMT2ACNR2 | |
| SCHEMBL31236334 | 0.87 | CA12 (0.42) | CA12CA2CA7CA9CA14 | |
| SCHEMBL28388477 | 0.82 | FAAH (0.43) | CA12CA2CA7CA9CA14 | |
| SCHEMBL28405424 | 0.81 | MAPT (0.39) | CA12CA2CA7CA9CA14 | |
| SCHEMBL27500926 | 0.80 | CNR2 (0.48) | FAAHCES1MEN1CYP1A2KMT2A | |
| SCHEMBL28467259 | 0.80 | FAAH (0.50) | FAAHCES1MEN1CYP1A2KMT2A | |
| SCHEMBL26638038 | 0.78 | FAAH (0.39) | CA12CA2CA7CA9CA14 | |
| SCHEMBL28363752 | 0.78 | FAAH (0.39) | CA12CA2CA7CA9CA14 | |
| SCHEMBL28718241 | 0.77 | SLC6A5 (0.47) | FAAHCES1MEN1KMT2ACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008081348-A2 | METHOD AND COMPOSITION FOR PERMANENTLY SHAPING HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2008-07-10 | — | — | WO | claimed |
| US-20080025937-A1 | Method and composition for permanently shaping hair | PROCTER & GAMBLE COMPANY, THE | 2008-01-31 | — | — | US | claimed |
| EP-1880709-A1 | Method and composition for permanently shaping hair | Wella Aktiengesellschaft (DE) | 2008-01-23 | — | — | EP | claimed |
| WO-2008081348-A2 | METHOD AND COMPOSITION FOR PERMANENTLY SHAPING HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2008-07-10 | — | — | WO | disclosed |
| US-20080025937-A1 | Method and composition for permanently shaping hair | PROCTER & GAMBLE COMPANY, THE | 2008-01-31 | — | — | US | disclosed |
| EP-1880709-A1 | Method and composition for permanently shaping hair | Wella Aktiengesellschaft (DE) | 2008-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080025937-A1 | Method and composition for permanently shaping hair | DNMT3A, DNMT1, NACA | CA12 645/4885CA2 758/4885CA7 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.